BTIG Chief Market Technician Jonathan Krinsky thinks the market can “continue to make upside progress” into year-end and sees a new all-time high for the S&P 500 (SPX) above 6,100. However, volatility ...
On Friday, FiscalNote Holdings Inc (NOTE) stock saw a decline, ending the day at $1.14 which represents a decrease of $-0.06 or -5.00% from the prior close of $1.2. The stock opened at $1.25 and ...
BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating on the shares as ...
On Friday, IREN Ltd (IREN) stock saw a decline, ending the day at $10.71 which represents a decrease of $-0.63 or -5.56% from the prior close of $11.34. The stock opened at $11.3 and touched a low of ...
SunCar Technology Group (NASDAQ:SDA) is on watch after BTIG Research initiated coverage on the cloud-based provider of digitalized automotive services and auto e-insurance solutions with a Buy rating.
Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss why he's cautious on Apple and the market ...
According to a BTIG strategist, the rally in the index was rejected from the previous support trendline and even though there are still four days left for the Santa Claus rally to deliver gains, there ...
Equities research analysts at BTIG Research assumed coverage on shares of SunCar Technology Group (NASDAQ:SDA – Get Free ...
BTIG’s Jonathan Krinsky is bullish on AppLovin Corporation (NASDAQ:APP), Flutter Entertainment (NYSE:FLUT), DraftKings (NASDAQ:DKNG), and Roblox Corporation (NYSE:RBLX), as he tagged Buy ratings ...
BTIG raised the firm’s price target on Darden (DRI) to $205 from $195 and keeps a Buy rating on the shares after its Q2 ...
BTIG said it would be cautious on Apple's (NASDAQ:AAPL) stock heading into January 2025. Analyst Jonathan Krinsky said the market can continue to make upside progress into the year-end and see a ...
BTIG initiated coverage of Cartesian Therapeutics (RNAC) with a Buy rating and $42 price target Cartesian is pioneering the field of mRNA-based CART cell therapies for autoimmune disorders, the ...